Climb Bio Inc. CLYM on Thursday shared initial data from its ongoing Phase 1b portion of its Phase 1b/2a study of budoprutug ...

The study aims to assess the safety, pharmacodynamics, pharmacokinetics and tolerability of HBM9378 for COPD.

Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the ...

Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol 'SLBT”Transaction provides strategic capital to advance proprietary Gamma ...

Pivot Bio, one of the world's leading innovative agtech companies, today announced the addition of three strategic hires to support the company's next phase of growth. The new leaders bring expertise ...

ADCs have become a core pillar of cancer treatment as increasingly sophisticated design is translating into stronger efficacy ...